North America Saliva Test Devices Market - Industry Trends and Forecast to 2028

TABLE OF CONTENT

TABLE OF CONTENTS 1 INTRODUCTION 12 1.1 OBJECTIVES OF THE STUDY 12 1.2 MARKET DEFINITION 12 1.3 OVERVIEW OF NORTH AMERICA SALIVA TEST DEVICES MARKET 12 1.4 LIMITATIONS 13 1.5 MARKETS COVERED 14 2 MARKET SEGMENTATION 16 2.1 MARKETS COVERED 16 2.2 GEOGRAPHICAL SCOPE 17 2.3 YEARS CONSIDERED FOR THE STUDY 17 2.4 CURRENCY AND PRICING 17 2.5 DBMR TRIPOD DATA VALIDATION MODEL 18 2.6 MULTIVARIATE MODELLING 21 2.7 PRODUCT TYPE LIFELINE CURVE 22 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23 2.9 DBMR MARKET POSITION GRID 24 2.10 MARKET APPLICATION COVERAGE GRID 25 2.11 VENDOR SHARE ANALYSIS 26 2.12 SECONDARY SOURCES 27 2.13 ASSUMPTIONS 27 3 EXECUTIVE SUMMARY 28 4 PREMIUM INSIGHTS 31 5 NORTH AMERICA SALIVA TEST DEVICES MARKET: REGULATORY FRAMEWORK 32 6 MARKET OVERVIEW 34 6.1 DRIVERS 36 6.1.1 INCREASING NUMBER OF APPLICATIONS OF SALIVA IN THE MEDICAL SECTOR 36 6.1.2 INCREASING NUMBER OF PRODUCT APPROVALS FOR SALIVA COLLECTION 37 6.1.3 GROWING NEED FOR RAPID DIAGNOSIS OF LIFE-THREATENING DISEASES 37 6.1.4 INCREASING RESEARCH AND DEVELOPMENT IN SALIVA TESTING BY KEY MARKET PLAYERS 38 6.2 RESTRAINTS 39 6.2.1 STRINGENT GOVERNMENT REGULATION 39 6.2.2 SHORTAGE OF SKILLED PERSONNEL 39 6.2.3 ALTERNATIVES TO SALIVA COLLECTION 40 6.3 OPPORTUNITIES 40 6.3.1 EMERGENCE OF COVID-19 40 6.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 40 6.3.3 INCREASING HEALTHCARE INFRASTRUCTURE 41 6.4 CHALLENGES 42 6.4.1 LABORATORY SUPPLY SHORTAGES 42 6.4.2 HIGH COST OF R&D 42 7 IMPACT OF COVID-19 ON THE NORTH AMERICA SALIVA TEST DEVICES MARKET 43 7.1 AFTERMATH OF COVID-19 AND GOVERNMENT ROLE 44 7.2 IMPACT ON DEMAND 44 7.3 IMPACT ON PRICE 45 7.4 IMPACT ON SUPPLY CHAIN 46 7.5 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19 46 7.6 CONCLUSION 47 8 NORTH AMERICA SALIVA TEST DEVICES MARKET, BY PRODUCT TYPE 48 8.1 OVERVIEW 49 8.2 PORTABLE DEVICES 52 8.3 TABLE TOP DEVICES 52 9 NORTH AMERICA SALIVA TEST DEVICES MARKET, BY TYPE 53 9.1 OVERVIEW 54 9.2 6-PANEL SALIVA TEST KITS 57 9.3 12-PANEL SALIVA TEST KITS 57 9.4 5-PANEL SALIVA TEST KITS 57 9.5 10-PANEL SALIVA TEST KITS 58 9.6 OTHERS 58 10 NORTH AMERICA SALIVA TEST DEVICES MARKET, BY FORM 59 10.1 OVERVIEW 60 10.2 STRIPS 63 10.3 SWABS 63 10.4 CASSETTES 63 11 NORTH AMERICA SALIVA TEST DEVICES MARKET, BY DETECTION 64 11.1 OVERVIEW 65 11.2 DRUGS 68 11.2.1 OPIOIDS 68 11.2.2 MARIJUANA (THC) 68 11.2.3 COCAINE 68 11.2.4 AMPHETAMINES 68 11.2.5 ALCOHOL 69 11.2.6 OTHER 69 11.3 ANTIBODIES 69 11.4 VIRUSES AND BACTERIA 69 11.5 HORMONES 69 11.5.1 CORTISOL 70 11.5.2 ESTROGENS 70 11.5.3 PROGESTERONE 70 11.5.4 ANDROGENS 70 11.6 ANTIGENS 70 11.7 OTHERS 70 12 NORTH AMERICA SALIVA TEST DEVICES MARKET, BY APPLICATION 72 12.1 OVERVIEW 73 12.2 CRIMINAL JUSTICE TESTING 76 12.3 WORKPLACE TESTING 76 12.4 DISEASE TESTING 76 13 NORTH AMERICA SALIVA TEST DEVICES MARKET, BY END USER 78 13.1 OVERVIEW 79 13.2 HOSPITALS 82 13.2.1 ACUTE CARE HOSPITALS 82 13.2.2 LONG-TERM CARE HOSPITALS 82 13.2.3 OTHERS 82 13.3 INVESTIGATION LABORATORIES 82 13.4 DIAGNOSTIC CENTERS 83 13.5 OTHERS 83 14 NORTH AMERICA SALIVA TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL 84 14.1 OVERVIEW 85 14.2 DIRECT TENDER 88 14.3 RETAIL SALES 88 14.4 THIRD PARTY DISTRIBUTION 88 15 NORTH AMERICA SALIVA TEST DEVICES MARKET BY COUNTRY 90 15.1 NORTH AMERICA 90 15.1.1 U.S. 95 15.1.2 CANADA 98 15.1.3 MEXICO 101 16 NORTH AMERICA SALIVA TEST DEVICES MARKET: COMPANY LANDSCAPE 104 16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 104 17 SWOT ANALYSIS 105 18 COMPANY PROFILE 106 18.1 ABBOTT 106 18.1.1 COMPANY SNAPSHOT 106 18.1.2 REVENUE ANALYSIS 106 18.1.3 PRODUCT PORTFOLIO 107 18.1.4 RECENT DEVELOPMENT 107 18.2 NEOGEN CORPORATION 108 18.2.1 COMPANY SNAPSHOT 108 18.2.2 REVENUE ANALYSIS 108 18.2.3 SOLUTION PORTFOLIO 109 18.2.4 RECENT DEVELOPMENT 109 18.3 ORASURE TECHNOLOGIES, INC. 110 18.3.1 COMPANY SNAPSHOT 110 18.3.2 REVENUE ANALYSIS 110 18.3.3 PRODUCT PORTFOLIO 111 18.3.4 RECENT DEVELOPMENTS 111 18.4 ALFA SCIENTIFIC DESIGNS, INC. 113 18.4.1 COMPANY SNAPSHOT 113 18.4.2 PRODUCT PORTFOLIO 113 18.4.3 RECENT DEVELOPMENT 113 18.5 AVELLINO 114 18.5.1 COMPANY SNAPSHOT 114 18.5.2 PRODUCT PORTFOLIO 114 18.5.3 RECENT DEVELOPMENTS 114 18.6 BTNX INC. 115 18.6.1 COMPANY SNAPSHOT 115 18.6.2 PRODUCT PORTFOLIO 115 18.6.3 RECENT DEVELOPMENT 115 18.7 CONFIRM BIOSCIENCES 116 18.7.1 COMPANY SNAPSHOT 116 18.7.2 PRODUCT PORTFOLIO 116 18.7.3 RECENT DEVELOPMENT 116 18.8 DNA GENOTEK INC. (A SUBSIDIARY OF ORASURE TECHNOLOGIES, INC.) 117 18.8.1 COMPANY SNAPSHOT 117 18.8.2 REVENUE ANALYSIS 117 18.8.3 PRODUCT PORTFOLIO 118 18.8.4 RECENT DEVELOPMENT 118 18.9 GC AMERICA INC. 119 18.9.1 COMPANY SNAPSHOT 119 18.9.2 PRODUCT PORTFOLIO 119 18.9.3 RECENT DEVELOPMENT 119 18.10 IMMUNALYSIS CORPORATION 120 18.10.1 COMPANY SNAPSHOT 120 18.10.2 PRODUCT PORTFOLIO 120 18.10.3 RECENT DEVELOPMENT 120 18.11 OASIS DIAGNOSTICS CORPORATION 121 18.11.1 COMPANY SNAPSHOT 121 18.11.2 PRODUCT PORTFOLIO 121 18.11.3 RECENT DEVELOPMENTS 121 18.12 ORANOXIS INC. 123 18.12.1 COMPANY SNAPSHOT 123 18.12.2 PRODUCT PORTFOLIO 123 18.12.3 RECENT DEVELOPMENTS 123 18.13 PREMIER BIOTECH, INC. 125 18.13.1 COMPANY SNAPSHOT 125 18.13.2 PRODUCT PORTFOLIO 125 18.13.3 RECENT DEVELOPMENT 125 18.14 SALIMETRICS, LLC 126 18.14.1 COMPANY SNAPSHOT 126 18.14.2 PRODUCT PORTFOLIO 126 18.14.3 RECENT DEVELOPMENTS 127 18.15 SECURETEC 128 18.15.1 COMPANY SNAPSHOT 128 18.15.2 PRODUCT PORTFOLIO 128 18.15.3 RECENT DEVELOPMENT 128 18.16 THERMO FISHER SCIENTIFIC INC. 129 18.16.1 COMPANY SNAPSHOT 129 18.16.2 REVENUE ANALYSIS 129 18.16.3 PRODUCT PORTFOLIO 130 18.16.4 RECENT DEVELOPMENT 130 18.17 VITAGENE 131 18.17.1 COMPANY SNAPSHOT 131 18.17.2 PRODUCT PORTFOLIO 131 18.17.3 RECENT DEVELOPMENTS 131 19 QUESTIONNAIRE 133 20 RELATED REPORTS 137